Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Herstellerkennzeichnung
Die Herstellerinformationen sind derzeit nicht verfügbar.
Inhaltsangabe
Introductory Remarks.- Methodology and Physiology Chairmen: G.V.R. Born and K. Breddin.- The Platelet as an Inflammatory Cell.- Platelet Aggregation in the Pathogenesis of Cerebrovascular Disorders.- The Mathematical Analysis of the Human Platelet Aggregation Mechanism and Its Clinical Application.- Quantitative Valuation of Platelet Aggregation Curves through the Calculation of a Numerical Index.- The Polyunsaturated Fatty Acids in Human Platelets: Effects of Diet and Possible Functional Significance.- Enhanced Platelet Aggregation as a Risk Factor for Progress and Complications of Vascular Disease. New Findings with a Platelet Aggregation Test (PAT III) and on the Dependence of Different Aggregation Tests on Morphologic Platelet Changes.- Pathogenesis Chairmen: M. Anthony, T. Abe, E.J. Acheson, J.S. Meyer, J. Marshall, K.J. Zülch.- Thrombosis and Embolism as a Cause of Ischemic Cerebrovascular Disturbances. Analysis from a Series of 1000 Patients.- Platelet Adhesiveness and Cerebral Vascular Disease Revisited.- The Significance of Platelet Aggregation in Amaurosis Fugax.- Mechanisms of Platelet 5-Hydroxytryptamine Release in Migraine.- Experimental observations on Platelet Emboli in Focal Brain Ischemia.- Observations on Platelet Aggregability in the Acute Phase of Untreated Strokes.- Microembolism in the Nervous System.- Influence of Plasma Components in the Development of Conditions of Increased Platelet Aggregation Found in a Number of Vascular Diseases.- Mechanism Associated with Platelet Adhesiveness in Cerebrovascular Disease.- Regional Intravascular Coagulation and Microthrombosis in Traumatic Brain Lacerations in Man.- Platelet Aggregation in Cerebrovascular Patients.- In Vivo Effect of Cyclic AMP and Related Drugs on Platelet Function.- PlateletHyperreactivity and Decreased Survival in Chronic Cerebrovascular Patients. Chronic Defibrination Syndrome?.- Arterial Hypertension and Platelet Aggregation in the Patho-Pathogenesis of Cerebrovascular Diseases.- Smoking, Cerebrovascular Diseases and Platelet Functions.- Contribution of Platelet Aggregation and Serotonin Release to Progressive Cerebral Infarction.- Effect of Agents which Modify Platelet Aggregation and/or Coagulation on Experimental Platelet Embolism and Intravascular Coagulation.- Platelet Abnormalities in Cerebrovascular Diseases.- Inhibition of Platelet Aggregation by Synthetic Organic Acids: Quantitative Relationships Between Chemical Structures and Biological Activities.- Some Observations of Platelet Changes in Atherosclerosis and Some Observations in the Platelet Alterations Before and After Antiaggregant Drugs in Normal and Atherosclerotics.- Pharmacology and Clinical Pharmacology Chairmen: C.A. Bouvier, W.S. Fields, O.N. Ulutin, A. Rascol.- Inhibition of Platelet Thrombus Formation by Pharmacological Agents.- A Long-Term Clinical Trial with Antiplatelet Agents in Cerebrovascular Ischemia: Biological and Methodological Aspects.- Effect of Aspirin and Dipyridamole on Platelet Function and on Neurologic Evaluation of Patients Affected by Stroke or Transient Ischemic Attacks.- The Pharmacologic Control of the Enhanced Platelet Aggregation in Preventive Neurology.- Aspirin in Cerebral Ischemia.- The Canadian Cooperative Studies of the Effect of Platelet-Suppressing Drugs in Transient Cerebral Ischemic Attacks.- On the Relationships Between the Activation of the Complement System and the Platelet Aggregation.- Discussion and Concluding Remarks.- Chairmen's Considerations.- Concluding Remarks.
Introductory Remarks.- Methodology and Physiology Chairmen: G.V.R. Born and K. Breddin.- The Platelet as an Inflammatory Cell.- Platelet Aggregation in the Pathogenesis of Cerebrovascular Disorders.- The Mathematical Analysis of the Human Platelet Aggregation Mechanism and Its Clinical Application.- Quantitative Valuation of Platelet Aggregation Curves through the Calculation of a Numerical Index.- The Polyunsaturated Fatty Acids in Human Platelets: Effects of Diet and Possible Functional Significance.- Enhanced Platelet Aggregation as a Risk Factor for Progress and Complications of Vascular Disease. New Findings with a Platelet Aggregation Test (PAT III) and on the Dependence of Different Aggregation Tests on Morphologic Platelet Changes.- Pathogenesis Chairmen: M. Anthony, T. Abe, E.J. Acheson, J.S. Meyer, J. Marshall, K.J. Zülch.- Thrombosis and Embolism as a Cause of Ischemic Cerebrovascular Disturbances. Analysis from a Series of 1000 Patients.- Platelet Adhesiveness and Cerebral Vascular Disease Revisited.- The Significance of Platelet Aggregation in Amaurosis Fugax.- Mechanisms of Platelet 5-Hydroxytryptamine Release in Migraine.- Experimental observations on Platelet Emboli in Focal Brain Ischemia.- Observations on Platelet Aggregability in the Acute Phase of Untreated Strokes.- Microembolism in the Nervous System.- Influence of Plasma Components in the Development of Conditions of Increased Platelet Aggregation Found in a Number of Vascular Diseases.- Mechanism Associated with Platelet Adhesiveness in Cerebrovascular Disease.- Regional Intravascular Coagulation and Microthrombosis in Traumatic Brain Lacerations in Man.- Platelet Aggregation in Cerebrovascular Patients.- In Vivo Effect of Cyclic AMP and Related Drugs on Platelet Function.- PlateletHyperreactivity and Decreased Survival in Chronic Cerebrovascular Patients. Chronic Defibrination Syndrome?.- Arterial Hypertension and Platelet Aggregation in the Patho-Pathogenesis of Cerebrovascular Diseases.- Smoking, Cerebrovascular Diseases and Platelet Functions.- Contribution of Platelet Aggregation and Serotonin Release to Progressive Cerebral Infarction.- Effect of Agents which Modify Platelet Aggregation and/or Coagulation on Experimental Platelet Embolism and Intravascular Coagulation.- Platelet Abnormalities in Cerebrovascular Diseases.- Inhibition of Platelet Aggregation by Synthetic Organic Acids: Quantitative Relationships Between Chemical Structures and Biological Activities.- Some Observations of Platelet Changes in Atherosclerosis and Some Observations in the Platelet Alterations Before and After Antiaggregant Drugs in Normal and Atherosclerotics.- Pharmacology and Clinical Pharmacology Chairmen: C.A. Bouvier, W.S. Fields, O.N. Ulutin, A. Rascol.- Inhibition of Platelet Thrombus Formation by Pharmacological Agents.- A Long-Term Clinical Trial with Antiplatelet Agents in Cerebrovascular Ischemia: Biological and Methodological Aspects.- Effect of Aspirin and Dipyridamole on Platelet Function and on Neurologic Evaluation of Patients Affected by Stroke or Transient Ischemic Attacks.- The Pharmacologic Control of the Enhanced Platelet Aggregation in Preventive Neurology.- Aspirin in Cerebral Ischemia.- The Canadian Cooperative Studies of the Effect of Platelet-Suppressing Drugs in Transient Cerebral Ischemic Attacks.- On the Relationships Between the Activation of the Complement System and the Platelet Aggregation.- Discussion and Concluding Remarks.- Chairmen's Considerations.- Concluding Remarks.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
